Skip to main content
What types of page to search?

Popular pages: Undergraduate Postgraduate PhD Accommodation Research International students

Alternatively use our A-Z index.

News

A nurse preps a patient arm for an injection

27 February 2026

US FDA accepts Teva’s New Drug Application (NDA) for Olanzapine long-acting injectable suspension for the monthly adult schizophrenia treatment
Two people stand back to back lifting their sleeves to show plasters covering their recent injections

27 February 2026

ViiV Healthcare reports long-acting injectable cabenuva effectively maintains viral suppression in adolescents living with HIV, with 97% preferring injections
Mycobacterium Tuberculosis Bacteria Scanning electron micrograph of Mycobacterium tuberculosis particles (colorized blue), the bacterium which causes TB. Credit: NIAID

20 February 2026

University at Buffalo researchers develop new inhalable treatment for TB
A syringe is being filled from a vial.

20 February 2026

ViiV Healthcare's long-acting cabenuva for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges
A graphic is HIV viruses

13 February 2026

Civil society demands access strategy for Merck’s promising long-acting HIV prevention pill covering all low- and middle- income countries
A large group of young people are walking around town in Rwanda

23 January 2026

Studies show that less frequent, all-injectable treatment for HIV is safe and preferred by adolescents
a model of a cross section of a brain on a worktop

16 January 2026

Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
A syringe is being filled from a vial.

16 January 2026

Sustained Therapeutics Reports Positive Phase 2 Results for its Long-Acting Non-Opioid Medication for Chronic Pain
A person is holiding an adult castor bean tick (Ixodes ricinus) caught in a glass vial.

2 January 2026

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease
A nurse preps a patient arm for an injection

26 December 2025

MHRA approves lenacapavir for the prevention of sexually transmitted HIV-1 infection
Scientists are working in their lab

19 December 2025

Exdensur approved in the UK and EU for treatment of asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps
A nurse preps a patient arm for an injection

19 December 2025

New study shows extended-release buprenorphine safely delivers rapid, clinically meaningful reductions in opioid use and supports abstinence
A nurse preps a patient arm for an injection

12 December 2025

Teva Pharmaceuticals submits New Drug Application to FDA for olanzapine extended-release injectable suspension for the once-monthly treatment of schizophrenia
A nurse preps a patient arm for an injection

5 December 2025

Generate:Biomedicines to initiate global phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI
A person holds a red AIDS awareness ribbon out to the camera

5 December 2025

New prevention tools and investment in services essential in the fight against AIDS
a syringe filled with light blue liquid

21 November 2025

Lupin launches risperidone long-acting injectable with 180-day CGT exclusivity in the US, the first product from its proprietary long-acting injectable platform
A syringe is being filled from a vial.

21 November 2025

LUPRON DEPOT® new strength receives Health Canada Approval for the treatment of advanced prostate cancer
a doctor is about to inject medicine into a patient\'s upper arm

21 November 2025

Arrivals of the twice-yearly PrEP option in Eswatini and Zambia mark an important milestone in the goal of ending the HIV epidemic in sub-Saharan Africa
a doctor is about to inject medicine into a patient\'s upper arm

21 November 2025

Phase 2 trial results show potential to shorten TB treatment time
A syringe is being filled from a vial in front of an HIV graphic

21 November 2025

Huge disparities in PrEP uptake across Europe – injectable PrEP largely inaccessible